Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis

Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis

Conversion of lysophosphatidylcholine to lysophosphatidic acid (LPA) by autotaxin, a secreted phospholipase D, is a major pathway for producing LPA. We previously reported that feeding Ldlr−/− mice standard mouse chow supplemented with unsaturated LPA or lysophosphatidylcholine qualitatively mimicke...

Full description

Bibliographic Details
Main Authors:	Arnab Chattopadhyay, Pallavi Mukherjee, Dawoud Sulaiman, Huan Wang, Victor Girjalva, Nasrin Dorreh, Jonathan P. Jacobs, Samuel Delk, Wouter H. Moolenaar, Mohamad Navab, Srinivasa T. Reddy, Alan M. Fogelman
Format:	Article
Language:	English
Published:	Elsevier 2023-05-01
Series:	Journal of Lipid Research
Subjects:	lysophospholipase D lysophosphatidic acid atherosclerosis oxidized phospholipids small intestine apolipoprotein A-I mimetic peptides
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227523000433

Similar Items

Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD[S]
by: Arnab Chattopadhyay, et al.
Published: (2016-05-01)

Autotaxin: structure-function and signaling
by: Anastassis Perrakis, et al.
Published: (2014-06-01)

Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice
by: Pallavi Mukherjee, et al.
Published: (2018-10-01)

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid[S]
by: Mohamad Navab, et al.
Published: (2013-12-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01)

Autotaxin in Pathophysiology and Pulmonary Fibrosis
by: Ioanna Ninou, et al.
Published: (2018-06-01)

Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum
by: Pallavi Mukherjee, et al.
Published: (2017-08-01)

Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine
by: M. Gauster, et al.
Published: (2005-07-01)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
by: Sha She, et al.
Published: (2022-06-01)

Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
by: Eunah Shin, et al.
Published: (2019-08-01)

Design and Development of Autotaxin Inhibitors
by: Yi Jia, et al.
Published: (2021-11-01)

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
by: Brian J. Van Lenten, et al.
Published: (2007-11-01)

Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
by: Matteo Centonze, et al.
Published: (2023-08-01)

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice
by: Mohamad Navab, et al.
Published: (2012-03-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01)

Autotaxin signaling facilitates β cell dedifferentiation and dysfunction induced by Sirtuin 3 deficiency
by: Cao, Huanyi, et al.
Published: (2023)

Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
by: Souvik Banerjee, et al.
Published: (2022-08-01)

Decrease in serum levels of autotaxin in COVID-19 patients
by: Takuya Shimura, et al.
Published: (2022-12-01)

The Emerging Role of LPA as an Oncometabolite
by: Theodoros Karalis, et al.
Published: (2024-04-01)

The Expression Regulation and Biological Function of Autotaxin
by: Xiaotian Zhang, et al.
Published: (2021-04-01)

Role of autotaxin in systemic lupus erythematosus
by: Yumi Tsuchida, et al.
Published: (2023-04-01)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
by: Xianglan eYao, et al.
Published: (2012-03-01)

Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux[S]
by: David Meriwether, et al.
Published: (2016-07-01)

Endothelial Specific Deletion of Autotaxin Improves Stroke Outcomes
by: Susmita Bhattarai, et al.
Published: (2023-02-01)

Isolation of a Functional Gene Encoding Homologous Lysophospholipase from Indonesian Indigenous Bacillus halodurans CM1
by: SHANNI FERNANDA, et al.
Published: (2019-08-01)

Increased β‐endorphin and autotaxin in patients with prurigo
by: Takahiro Ishikawa, et al.
Published: (2019-08-01)

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet
by: Georgette M. Buga, et al.
Published: (2008-01-01)

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells
by: Elisa Matas-Rico, et al.
Published: (2021-11-01)

D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet
by: Georgette M. Buga, et al.
Published: (2006-10-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

Effects of autotaxin and lysophosphatidic acid deficiencies on depression-like behaviors in mice exposed to chronic unpredictable mild stress
by: Chao Wang, et al.
Published: (2024-05-01)

Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation
by: Pallavi Mukherjee, et al.
Published: (2022-01-01)

ADSCs and adipocytes are the main producers in the autotaxin–lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro
by: Rafael Schmid, et al.
Published: (2018-12-01)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I*
by: Brian J. Van Lenten, et al.
Published: (2008-11-01)

Surface loops of extracellular phospholipase A1 determine both substrate specificity and preference for lysophospholipids
by: Naoaki Arima, et al.
Published: (2012-03-01)

Phospholipase B activity of a purified phospholipase A from Vipera palestinae venom
by: J. Shiloah, et al.
Published: (1973-05-01)

Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
by: Konstantinos Ntatsoulis, et al.
Published: (2021-10-01)

A novel approach to oral apoA-I mimetic therapy[S]
by: Arnab Chattopadhyay, et al.
Published: (2013-04-01)

Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors
by: M.A. Deken, et al.
Published: (2023-06-01)

Autotaxin Activity in Chronic Subdural Hematoma: A Prospective Clinical Study
by: Theodosis Kalamatianos, et al.
Published: (2022-08-01)